Incidence of cytomegalovirus infection in kidney recipients.
Bilgin
N
N
Başkent University School of Medicine, Department of General Surgery, Ankara, Turkey.
Karakayali
H
H
Moray
G
G
Akkoç
H
H
Turan
M
M
D000914:Antibodies, Viral / Q000097:blood; D002102:Cadaver; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000453:epidemiology*; D005190:Family; D006084:Graft Rejection / Q000453:epidemiology / Q000628:therapy; D006085:Graft Survival; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D016030:Kidney Transplantation / Q000401:mortality; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011183:Postoperative Complications; D012189:Retrospective Studies; D016019:Survival Analysis; D014019:Tissue Donors; D014421:Turkey / Q000453:epidemiology
D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3